Martin S F
Allergy Research Group, Department of Dermatology, University Medical Center, Freiburg, Germany.
Allergol Select. 2017 Aug 4;1(1):39-43. doi: 10.5414/ALX01274E. eCollection 2017.
. Allergic contact dermatitis is a Tcell mediated inflammatory skin disease that is caused by low molecular weight chemicals and metal ions. These contact allergens induce skin inflammation, an essential element of the sensitization process. Our understanding of the molecular mechanisms that underlie chemical-induced inflammation has improved significantly over the last years. The emerging picture shows that contact allergens activate known innate immune and stress responses that play a role in immune responses to infections. Contact allergens use innate immune receptors such as the Toll-like receptors TLR2 and TLR4 and the NOD-like receptor NLRP3 as part of the inflammasome as well as the induction of oxidative stress to induce skin inflammation. The detailed identification of the relevant signaling pathways and the mechanisms of their activation by contact allergens will most likely lead to more targeted therapeutic approaches by interference with these pathways. Moreover, this will help to refine existing, and to develop new in vitro assays for the identification of contact allergens, an important step to replace animal testing e.g. for ingredients of cosmetics which has been prohibited now by EU legislation.
过敏性接触性皮炎是一种由低分子量化学物质和金属离子引起的T细胞介导的炎症性皮肤病。这些接触性过敏原会引发皮肤炎症,这是致敏过程的一个关键要素。在过去几年中,我们对化学物质诱导炎症背后的分子机制的理解有了显著提高。新出现的情况表明,接触性过敏原会激活已知的固有免疫和应激反应,这些反应在对感染的免疫反应中发挥作用。接触性过敏原利用固有免疫受体,如Toll样受体TLR2和TLR4以及作为炎性小体一部分的NOD样受体NLRP3,以及诱导氧化应激来引发皮肤炎症。详细鉴定相关信号通路及其被接触性过敏原激活的机制,很可能会通过干扰这些通路导致更具针对性的治疗方法。此外,这将有助于完善现有的体外检测方法,并开发新的体外检测方法来鉴定接触性过敏原,这是取代动物试验的重要一步,例如用于化妆品成分的动物试验,目前已被欧盟立法禁止。